A. Mohamed.

Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function.

M. Pollak, Opeyemi A. Olabisi, Jia-yue Zhang, 2020, Journal of the American Society of Nephrology : JASN.